N-Me-Ile-OH

Name: N-Me-Ile-OH | 4125-98-8
Brand: US-CATO
SKU: S57CPTD787626_10_MG
Price: 19998.0 USD
Availability: OutOfStock

Cat. No S57CPTD787626_10_MG

Vendor: US-CATO

Product Information

Product Name

N-Me-Ile-OH

Brand Name

US-CATO

Product Number

CPTD787626

CAS

4125-98-8

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

5288628

IUPAC Name

(2S,3S)-3-methyl-2-(methylamino)pentanoic acid

InChI Key

KSPIYJQBLVDRRI-WDSKDSINSA-N

SMILES

CCC@H(C)C@@H(C(=O)O)NC

References Data Source From Pubchem

Unlocking the Therapeutic Potential of Cyclic Peptide-Based Nanocarriers for Enhanced Colon Cancer Treatment

Publication Name: The Protein Journal

Publication Date: 2025-10-05

DOI: 10.1007/s10930-025-10289-2

Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus

Publication Name: Nature reviews. Endocrinology

Publication Date: 2025-05-13

DOI: 10.1038/s41574-025-01125-9

Evaluating treatment responsiveness in rheumatoid arthritis through predictive metabolomic profiling: A systematic review of studies examining methotrexate, TNF, and IL-6 inhibitors as therapeutic interventions

Publication Name: Clinical Rheumatology

Publication Date: 2025-02-10

DOI: 10.1007/s10067-025-07355-6

Late Nucleosynthesis and Supernovae

Publication Name: Universe, Neutrinos, Stars and Life

Publication Date: 2025

DOI: 10.1007/978-3-662-70729-6_9

Introduction to Clinical Applications of Biomolecules in Disease Diagnosis

Publication Name: Clinical Applications of Biomolecules in Disease Diagnosis

Publication Date: 2024

DOI: 10.1007/978-981-97-4723-8_1

N-Me-Ile-OH

Product Information

General Information

References Data Source From Pubchem

Unlocking the Therapeutic Potential of Cyclic Peptide-Based Nanocarriers for Enhanced Colon Cancer Treatment

Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus

Evaluating treatment responsiveness in rheumatoid arthritis through predictive metabolomic profiling: A systematic review of studies examining methotrexate, TNF, and IL-6 inhibitors as therapeutic interventions

Late Nucleosynthesis and Supernovae

Introduction to Clinical Applications of Biomolecules in Disease Diagnosis

N-Me-Ile-OH

Mycophenolate Mofetil EP Impurity H

Mycophenolate Mofetil

Flurbiprofen Impurity 21 (Mixture of Diastereomers)

Docetaxel Impurity 40

H-Met-Glu-OH

Fluticasone Impurity 106

Efavirenz Related Compound C

Cholecalciferol EP Impurity A

About Us

Popular Searches

Contact

#title#

Features
Availability:
Price
Options
Actions

N-Me-Ile-OH

Product Information

General Information

References Data Source From Pubchem

Unlocking the Therapeutic Potential of Cyclic Peptide-Based Nanocarriers for Enhanced Colon Cancer Treatment

Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus

Evaluating treatment responsiveness in rheumatoid arthritis through predictive metabolomic profiling: A systematic review of studies examining methotrexate, TNF, and IL-6 inhibitors as therapeutic interventions

Late Nucleosynthesis and Supernovae

Introduction to Clinical Applications of Biomolecules in Disease Diagnosis

N-Me-Ile-OH

Related Product

Mycophenolate Mofetil EP Impurity H

Mycophenolate Mofetil

Flurbiprofen Impurity 21 (Mixture of Diastereomers)

Docetaxel Impurity 40

H-Met-Glu-OH

Fluticasone Impurity 106

Efavirenz Related Compound C

Cholecalciferol EP Impurity A

#title#

Login

Register